MADE FOR LIFE, BUILT FOR IMPACT
Talking with Steven LoGiudice, Manager, Business Strategy and Maryanne McHugh, Global Strategic Advisor, Canon Healthcare USA
Canon Healthcare USA is on a mission to shape the future of healthcare through innovation, strategy, and collaboration. At the forefront of that effort is Steven LoGiudice and Maryanne McHugh, seasoned healthcare executives with a passion for solving complex challenges and purpose-driven leadership. In this Q&A, Steven and Maryanne share how Canon Healthcare USA is bridging global research with real-world application, aligning business strategy with clinical insight, and building meaningful partnerships to realize Canon Medical’s Made for Life vision.
Why are you expanding your presence in healthcare, and how do stand?
Steven LoGiudice: Canon has always been about innovation and “living and working for the common good.” There is no better industry in which to have this kind of positive impact than healthcare. The establishment of Canon Healthcare USA demonstrates Canon’s keen focus and commitment to the U.S. healthcare industry.
Canon Healthcare USA was established to ensure that our entire medical business is embedded within the U.S. market and develops deep relationships with providers. We aim to understand the issues they are dealing with and the pain points they are trying to solve. Our in-depth knowledge enables us to develop solutions that are uniquely targeted for the needs of hospitals, health systems, and others within the industry.
What trends and challenges in healthcare are shaping the technologies and solutions of tomorrow?
LoGiudice: Today’s challenges include funding reductions, the potential for millions of Americans to lose insurance coverage, changes in scientific focus, federal grant funding changes, and tariff and immigration policies. As a result, the interplay of these items could change the healthcare ecosystem in ways that are especially hard to predict.
One way that providers are managing this change is by focusing on the fundamentals of efficiency and value. Therefore, the solutions that help providers reduce costs, become more efficient, and function in a value-based environment will stick. In fact, we are seeing a rapid uptick of ambient AI in clinical settings to reduce the administrative burden on clinicians and enable them to spend quality time with patients.
Currently, we are paying close attention to the changing landscape of NIH (National Institute of Health) research funding. Not only does this have a direct impact on patient care through diagnostic and treatment innovations, but there is indirect impact on venture and private-sector funding. In turn, how the U.S. adapts long-term models for funding of biomedical research will have a significant long-term impact on what our healthcare ecosystem looks like 5-10 years from now.
How do you translate ambitious ideas into practical solutions that meet the day-to-day needs of patients, clinicians, and healthcare administrators?
Maryanne McHugh: We are privileged to work in an industry fueled by innovation, collaboration and the constant quest for improvements in patient care that leads to improved quality of life for us all. Our challenge is to productize ideas in ways that ensure they are adopted by the market and so they can contribute to the cause.
Our newly established Cleveland organization’s mission includes exploring the potential market for innovations while ensuring those solutions meet real needs. We aim to improve the working environment of healthcare professionals and demonstrate provable clinical benefit that can be commercialized in an economically, environmentally, and socially sustainable fashion.
Can you share how collaboration has directly influenced your business strategy or product development priorities?
McHugh: Many of Canon’s unique market-leading technologies have been developed directly with key collaborators. Just this year, a breakthrough concept in CT, Aquilion RISE, was introduced in Japan, allowing CT scanning in both the upright and horizontal positions. This expands clinical diagnosis and allows new understanding of weight-bearing effects on anatomy and physiology. Close collaboration with Professor Jinzaki of Keio University Hospital drove the development from a system that scanned only in vertical mode, to a system that could scan in “normal” horizontal mode so it could be used more widely across the healthcare system.
Canon’s Core 64 and Core 320 Aquilion CT Cardiac Multicenter trials led by Johns Hopkins here in the U.S. contributed significantly to the development of coronary artery imaging as a viable clinical tool, and heavily influenced Canon’s ongoing investment in developing cardiology solutions in CT.
“We are privileged to work in an industry fueled by innovation, collaboration and the constant quest for improvements in patient care that leads to improved quality of life for us all.”
– Maryanne McHugh, Global Strategic Advisor, Canon Medical Systems Corporation
What do you see as the most pressing areas where Canon Healthcare can differentiate itself in the U.S. healthcare landscape?
LoGuidice: Science and biotechnology are pushing healthcare toward a more personalized care future. So, we are very focused on deciphering business context, and driving discussion on what the industry will look like in 5-10 years. We can’t know for sure, but we can use the tools of futurism to implement structured thinking and planning so the organization knows where to place its bets.
We believe that personalized (or precision) medicine has the potential to fundamentally change how healthcare is delivered and consumed in this country. One uncertainty, of course, is the speed at which this future may arise and how equitable it will be. But it is vital for us as a healthcare organization to understand this, play a role in supporting the development of a personalized medicine future, and—most importantly—work in close collaboration with health system partners in supporting their transition to this future.
How do you ensure that the “Made for Life” vision isn’t just aspirational but actively shapes decision-making, partnerships, and patient outcomes?
LoGuidice: Made for Life reflects Canon Medical’s management philosophy and belief that quality of life should be a given, not the exception. It is a commitment to our customers, our partners, and patients, that everything we do is through the lens of contributing to their well-being, whether through improving health outcomes, professional performance or workplace efficiency and safety.
As an example, the growth in value-based care has been discussed for decades, but has never really scaled. The new leadership at CMS appears committed to value-based models, and has stated that they wish to expand participation in these models by independent providers, community health centers, and rural providers. We see more and more signals that incremental change will continue and may reach a tipping point where value-based models become more common. Additionally, we see more health systems looking to focus their activity earlier in the care continuum—away from illness-based interventions in ER and inpatient settings and toward activities such as prevention and care in home and community settings. Guided by “Made for Life,” we need to ensure that Canon is ready for this possible transition in care by creating products and solutions that meet the industry—and its patients —where it is headed.
